Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karen Wright, MD
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Phoenix Children'S Hospital Center for Cancer and Blood Disorders
Phoenix, Arizona, United States
- the Children'S Hospital
Denver, Colorado, United States
- University of Florida College of Medicine
Gainesville, Florida, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- John Hopkins Medical Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Institute
New York, New York, United States
- New York University
New York, New York, United States
- Doernbecher Children'S Hospital Oregon Health & Science University
Portland, Oregon, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2009
- Primary completion
- 31 Aug 2012
- Completion
- 31 Aug 2012
- Last update posted
- 15 Aug 2018
- Registered enrollment
- 23
- Registry id
- NCT00782626
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.